PP 242

CAS No. 1092351-67-1

PP 242( PP242 | PP-242 )

Catalog No. M10346 CAS No. 1092351-67-1

A potent, specific active-site inhibitor of mTOR with IC50 of 30 and 58 nM for mTORC1 and mTORC2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 61 In Stock
25MG 87 In Stock
50MG 124 In Stock
100MG 215 In Stock
200MG 320 In Stock
500MG 530 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PP 242
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, specific active-site inhibitor of mTOR with IC50 of 30 and 58 nM for mTORC1 and mTORC2, respectively.
  • Description
    A potent, specific active-site inhibitor of mTOR with IC50 of 30 and 58 nM for mTORC1 and mTORC2, respectively; shows no activity against PKC-β, RET, or JAK2 but inhibits PKC-α (IC50=50 nM); blocks the phosphorylation of Akt at S473 and prevents its full activation, inhibits proliferation of primary cells more completely than rapamycin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PP242 | PP-242
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    DNA-PK|Hck|mTOR|p110δ|PDGFR|mTORC1|mTORC2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1092351-67-1
  • Formula Weight
    308.3378
  • Molecular Formula
    C16H16N6O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    OC1=CC2=C(NC(C3=NN(C(C)C)C4=NC=NC(N)=C43)=C2)C=C1
  • Chemical Name
    1H-Indol-5-ol, 2-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Janes MR, et al. Nat Med. 2010 Feb;16(2):205-13. 2. Feldman ME, et al. PLoS Biol. 2009 Feb 10;7(2):e38. 3. Hoang B, et al. J Biol Chem. 2012 Jun 22;287(26):21796-805. 4. Hsieh AC, et al. Cancer Cell. 2010 Mar 16;17(3):249-61.
molnova catalog
related products
  • DMH-25

    DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.

  • S6K1-IN-DG2

    S6K1-IN-DG2(S6K1InhibitorDG2) is a potent p70S6K inhibitor with an IC50 value of less than 100 nM.

  • Tacrolimus

    Tacrolimus is a macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity.